Legis Daily

Zero Tolerance for Deceptive Fentanyl Trafficking Act

USA116th CongressS-3342| Senate 
| Updated: 2/27/2020
Tom Cotton

Tom Cotton

Republican Senator

Arkansas

Cosponsors (2)
Marsha Blackburn (Republican)Kelly Loeffler (Republican)

Judiciary Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Zero Tolerance for Deceptive Fentanyl Trafficking Act This bill adds five fentanyl analogues and the entire category of fentanyl-related substances to schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Additionally, the bill establishes a new criminal offense and penalties with respect to the deceptive sale of fentanyl, fentanyl analogues, or fentanyl-related substances.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 27, 2020
Introduced in Senate
Feb 27, 2020
Read twice and referred to the Committee on the Judiciary.
  • February 27, 2020
    Introduced in Senate


  • February 27, 2020
    Read twice and referred to the Committee on the Judiciary.

Crime and Law Enforcement

Related Bills

  • S 116-3148: Stopping Overdoses of Fentanyl Analogues Act
  • S 116-2701: Federal Initiative to Guarantee Health by Targeting Fentanyl Act
  • HR 116-2935: Stopping Overdoses of Fentanyl Analogues Act
  • S 116-1622: Stopping Overdoses of Fentanyl Analogues Act
  • HR 116-5771: Federal Initiative to Guarantee Health by Targeting Fentanyl Act
Border security and unlawful immigrationCriminal procedure and sentencingDrug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesMarketing and advertising

Zero Tolerance for Deceptive Fentanyl Trafficking Act

USA116th CongressS-3342| Senate 
| Updated: 2/27/2020
Zero Tolerance for Deceptive Fentanyl Trafficking Act This bill adds five fentanyl analogues and the entire category of fentanyl-related substances to schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Additionally, the bill establishes a new criminal offense and penalties with respect to the deceptive sale of fentanyl, fentanyl analogues, or fentanyl-related substances.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 27, 2020
Introduced in Senate
Feb 27, 2020
Read twice and referred to the Committee on the Judiciary.
  • February 27, 2020
    Introduced in Senate


  • February 27, 2020
    Read twice and referred to the Committee on the Judiciary.
Tom Cotton

Tom Cotton

Republican Senator

Arkansas

Cosponsors (2)
Marsha Blackburn (Republican)Kelly Loeffler (Republican)

Judiciary Committee

Crime and Law Enforcement

Related Bills

  • S 116-3148: Stopping Overdoses of Fentanyl Analogues Act
  • S 116-2701: Federal Initiative to Guarantee Health by Targeting Fentanyl Act
  • HR 116-2935: Stopping Overdoses of Fentanyl Analogues Act
  • S 116-1622: Stopping Overdoses of Fentanyl Analogues Act
  • HR 116-5771: Federal Initiative to Guarantee Health by Targeting Fentanyl Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Border security and unlawful immigrationCriminal procedure and sentencingDrug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesMarketing and advertising